The price for taking equity risk in Germany remains surprisingly low despite geopolitical turbulence. Our latest analysis delves into this phenomenon and explores the factors shaping market valuations in Germany, the US, and Europe.
Key takeaways:
- Industry multiples are hit by higher prospects on forecasted EBITDA levels not captured (yet) by increases in EVs
- US firms command a premium over CDAX firms, mostly as US stocks benefit from brighter profitability outlooks
- In the European M&A market, prices in Healthcare and Transport & Logistics deals outperformed trading levels
Read our full insight piece for a detailed analysis and expert insights.
The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.